Young Suk Park
Seoul National University Bundang Hospital · Samsung Medical Center, South Korea · Samsung Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Young Suk Park as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:32 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05211375 · Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled TrialSeoul National University Bundang Hospital · recruiting · Diabetes Mellitus, Type 2, Bariatric Surgery, Surgical Procedures, Operative · principal investigator
- Ph3NCT01996306 · A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRCEpidemiological and Clinical Research Information Network · completed · Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms · principal investigator
- Ph1NCT01469611 · A Trial of JX-594 in Refractory Colorectal CarcinomaSamsung Medical Center · completed · Colorectal Carcinoma · principal investigator
- Ph1NCT01380600 · Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal CarcinomaJennerex Biotherapeutics · completed · Carcinoma, Colorectal · principal investigator
- Ph3NCT01092481 · Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer TherapySamsung Medical Center · unknown · Colon Cancer · principal investigator
- Ph2NCT00944463 · Trial of Simvastatin and Gemcitabine in Pancreatic Cancer PatientsSamsung Medical Center · completed · Pancreatic Cancer · principal investigator
- Ph2NCT00743678 · Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver MetastasisSamsung Medical Center · completed · Colorectal Cancer, Unresectable Liver Metastasis · principal investigator
- Ph3NCT00677443 · Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal CancerSamsung Medical Center · completed · Colorectal Cancer · study chair
- Ph1NCT00539877 · Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal SeedingSamsung Medical Center · completed · Stomach Neoplasms · principal investigator
- Ph1/Ph2NCT00533533 · A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric CancerSamsung Medical Center · completed · Gastric Cancer · principal investigator
- Ph1/Ph2NCT00531245 · A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal CancerSamsung Medical Center · completed · Colorectal Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 25 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:32 UTC. The ranking covers the 200 most relevant of 284 PubMed records, and a shared surname and initials can bring in a namesake. All 284 on PubMed
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.Nat Med · 20181,396 citationsRCR 45.0
- 627 citationsRCR 18.8
- Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone.J Clin Oncol · 2012521 citationsRCR 14.3
- Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.Lancet Oncol · 2012377 citationsRCR 10.1
- 344 citationsRCR 11.6
- Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.Lancet Oncol · 2011334 citationsRCR 7.9
- 322 citationsRCR 19.6
- Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.J Clin Oncol · 2007237 citationsRCR 5.8
- 235 citationsRCR 15.5
- 231 citationsRCR 7.6